摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-iodo-harmine | 234755-96-5

中文名称
——
中文别名
——
英文名称
8-iodo-harmine
英文别名
8-iodoharmine;8-iodo-7-methoxy-1-methyl-9H-pyrido[3,4-b]indole
8-iodo-harmine化学式
CAS
234755-96-5
化学式
C13H11IN2O
mdl
——
分子量
338.148
InChiKey
FMBKFOPHJNVRKU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    37.9
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    8-iodo-harmine 在 copper(I) chloride 、 sodium iodide 作用下, 以 phosphate buffer 、 乙醇 为溶剂, 反应 0.17h, 生成 8-[131I]-iodo-harmine
    参考文献:
    名称:
    Iodination, radioiodination and spectroscopic identification of β-carboline derivatives
    摘要:
    The synthesis and spectral properties (MS, and NMR) of radioiodinated beta-carbolines: 6-(I) and 8- (II) [I-131]-iodo-1-methyl-7-methoxy-beta-carboline ([I-131]-iodo-harmine), 6- (III) and 8- (IV) [I-131]-iodo-1-methyl-beta-carboline-7-ol ([I-131]-iodo-harmol), 8-[I-131]-iodo-1-methyl-7-methoxy-3,4-dihydro-beta-carboline (8-[I-131]-iodo-harmaline) (V), 8-[I-131]-iodo-3,4-dihydro-1-methyl-beta-carboline-7-ol (8-[I-131]-iodo-harmalol) (VI), 6-[I-131]-iodo-1-methyl-beta-carboline (6-[I-131]-iodo-harmane) (VII) are described. These are compounds of biological importance and can be used for brain mapping with SPECT technology.
    DOI:
    10.1002/(sici)1099-1344(199905)42:5<409::aid-jlcr195>3.0.co;2-a
  • 作为产物:
    描述:
    肉叶云香碱 、 thallium(III) trifluoroacetate 作用下, 生成 8-iodo-harmine
    参考文献:
    名称:
    A Facile High-Yield Synthesis of [10 B]-8-Dihydroxyboryl Harmine, a Potential Agent for Boron Neutron Capture Therapy
    摘要:
    不适用
    DOI:
    10.3390/50300526
点击查看最新优质反应信息

文献信息

  • SCREENING METHOD, PROTEIN INSTABILITY AND/OR STABILITY INDUCERS, AND PROTEIN ACTIVITY ASSESSMENT
    申请人:KYOTO UNIVERSITY
    公开号:US20150133467A1
    公开(公告)日:2015-05-14
    Provided is a screening method with which it is possible to determine the cause of a decrease or an increase in the amount of a target protein that is expressed by a cell. One or a plurality of embodiments include: conducting cultivation that includes bringing an assay cell into contact with a test substance, and measuring a relative amount (A) of the target protein in relation to an internal standard; conducting cultivation in which an assay cell is not brought into contact with a test substance, and measuring a relative amount (B) in relation to an internal standard; comparing the relative amount (A) and the relative amount (B); and, based on the comparison, selecting a candidate substance that induces instability and/or stability in the target protein. The assay cell is a cell that is able to express mRNA of the target protein and mRNA of the internal standard protein under the identical regulation of gene expression, or a cell having a means for expressing mRNA of the target protein and mRNA of the internal standard protein under the identical regulation of gene expression.
    提供了一种筛选方法,可以确定细胞表达的目标蛋白质数量减少或增加的原因。其中一种或多种实施方式包括:进行培养,将检测细胞与测试物质接触,并测量与内部标准相关的目标蛋白质的相对量(A);进行培养,其中检测细胞未与测试物质接触,并测量与内部标准相关的相对量(B);比较相对量(A)和相对量(B);并根据比较选择诱导目标蛋白质不稳定性和/或稳定性的候选物质。检测细胞是能够在基因表达的相同调节下表达目标蛋白质mRNA和内部标准蛋白质mRNA的细胞,或具有在基因表达的相同调节下表达目标蛋白质mRNA和内部标准蛋白质mRNA的手段的细胞。
  • COMPOUND PERTAINING TO NEUROPOIESIS AND DRUG COMPOSITION
    申请人:KYOTO UNIVERSITY
    公开号:US20160303089A1
    公开(公告)日:2016-10-20
    A composition for activating neurogenesis or the growth of neurons is provided. In one or more embodiments, a composition contains as an active ingredient a compound with a DYRK inhibitory capacity or a prodrug thereof or a pharmaceutically acceptable salt thereof. In one or more embodiments, a composition contains as an active ingredient a compound expressed by the following general formula (I) and/or (II) or prodrug thereof or a pharmaceutically acceptable salt thereof.
    提供了一种用于激活神经发生或神经元生长的组合物。在一个或多个实施例中,该组合物包含作为活性成分的具有DYRK抑制能力的化合物或其前药,或其药学上可接受的盐。在一个或多个实施例中,该组合物包含作为活性成分的符合以下一般式(I)和/或(II)的化合物,或其前药,或其药学上可接受的盐。
  • Synthesis of 8-[10B]-dihydroxyboryl-harmine, a potential agent for boron neutron capture therapy
    作者:Jose A. Sintas、Norberto J. Macareno、Arturo A. Vitale
    DOI:10.1002/(sici)1099-1344(200001)43:1<97::aid-jlcr296>3.0.co;2-d
    日期:2000.1
查看更多